LABStandard BioTools Inc
$0.8297
$0.0196
(2.42%)
Closed $0.8297
$0.0297
(3.58%)
After Hours
Mkt Cap$323.89M
Vol3.29M
Fundamentals
Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders?
Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders? Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 15, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...
PR Newswire
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Standard BioTools Inc. (NASDAQ: LAB) and Treeline Biosciences, Inc. Upon closing of the proposed transaction, Standard BioTools shareholders are expected to own approximately 16% of the combined company. Halper Sadeh...
Business Wire
Standard BioTools Signs Deal To Merge With Treeline Biosciences
(RTTNews) - Monday, Standard BioTools Inc. (LAB) announced an agreement with Treeline Biosciences, Inc., a clinical-stage biopharma company, to combine in an all-stock transaction...
Nasdaq News: Markets
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools (LAB) delivered earnings and revenue surprises of 0.00% and +13.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Beats Expectations By $0.35 EPS
Standard BioTools (NASDAQ:LAB - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus...
MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Sees Significant Drop in Short Interest
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 8,479,342 shares, a decline of 17.8% from the March 31st total of 10,319,954 shares. Based on an average daily...
MarketBeat
Standard BioTools (LAB) Projected to Post Earnings on Tuesday
Standard BioTools (NASDAQ:LAB) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Sees Large Growth in Short Interest
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 10,319,954 shares, a growth of 24.6% from the March 15th total of 8,281,198 shares. Currently, 3.4% of the...
MarketBeat
Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5%
Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 13th, there was short interest totaling 8,281,198 shares, a drop of 18.5% from the February 26th total of 10,159,609 shares. Approximately 2.8% of the shares of the...
MarketBeat
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Standard BioTools from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest LAB News
ViewAre ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders?
PR Newswire
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders
Business Wire
Standard BioTools Signs Deal To Merge With Treeline Biosciences
Nasdaq News: Markets
Advertisement|Remove ads.